Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.750
-0.070 (-1.45%)
Dec 2, 2025, 4:00 PM EST
Veradigm Market Cap
Veradigm has a market cap or net worth of $807.3 million as of December 3, 2025. Its market cap has decreased by -50.40% in one year.
Market Cap
807.30M
Enterprise Value
580.15M
Revenue
588.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.75
Market Cap Chart
Since October 13, 2008, Veradigm's market cap has increased from 311.82M to 807.30M, an increase of 158.90%. That is a compound annual growth rate of 5.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 807.30M | -51.17% |
| Dec 31, 2024 | 1.65B | 44.24% |
| Dec 29, 2023 | 1.15B | -40.53% |
| Dec 30, 2022 | 1.93B | -14.77% |
| Dec 31, 2021 | 2.26B | -0.87% |
| Dec 31, 2020 | 2.28B | 43.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 573.51M |
| Glass House Brands | 520.12M |
| CytoDyn | 416.55M |
| American Oncology Network | 363.17M |
| Northwest Biotherapeutics | 359.83M |
| Silence Therapeutics | 311.27M |
| Nika Pharmaceuticals | 259.91M |
| HST Global | 133.04M |